Milestone Pharmaceuticals Inc
(MIST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 1,000 | 3,500 | 1,500 | 0 | 0 |
| Gross Profit | 1,000 | 3,500 | 1,500 | N/A | N/A |
| Operating Expenses | 16,502 | 17,259 | 16,530 | 16,806 | 14,047 |
| Operating Income | -15,502 | -13,759 | -15,030 | -16,806 | -14,047 |
| Interest Expense | 33 | 0 | 0 | 0 | 0 |
| Other Income | 585 | 582 | 474 | 158 | 40 |
| Pre-tax Income | -14,950 | -13,177 | -14,556 | -16,648 | -14,007 |
| Net Income Continuous | -14,950 | -13,177 | -14,556 | -16,648 | -14,007 |
| Net Income | $-14,950 | $-13,177 | $-14,556 | $-16,648 | $-14,007 |
| EPS Basic Total Ops | -0.35 | -0.32 | -0.34 | -0.39 | -0.33 |
| EPS Basic Continuous Ops | -0.35 | -0.31 | -0.34 | -0.39 | -0.33 |
| EPS Diluted Total Ops | -0.35 | -0.32 | -0.34 | -0.39 | -0.33 |
| EPS Diluted Continuous Ops | -0.35 | -0.31 | -0.34 | -0.39 | -0.33 |
| EBITDA(a) | $-15,484 | $-13,744 | $-15,003 | $-16,782 | $-14,024 |